position: EnglishChannel > Visual?Stories > Article

ICGEB Accepted 20,000 Protective Face Masks Donation from Chinese Partners

Source: International Union for Science and Technology Communication| 2020-05-18 13:46:55| Author: ICGEB


The picture shows thatDr. Lawrance Banks(L) is distributing protective masks from China to the localhealth authorities in Trieste, Italy.

The International Center for Genetic Engineering and Biotechnology (ICGEB) is collaborating on many fronts with its partners in China, and in particular, with  China Medical City (CMC), Taizhou, location of the ICGEB Regional Research Centre, and the China National Center for Biotechnology Development (CNCBD), the branch of the Chinese Ministry of Science and Technology that is responsible for ICGEB in Beijing, China.

Dr. Lawrence Banks, ICGEB Director-General said:"In a wonderful show of international solidarity, medical equipment including 20,000 protective face masks, have been donated from our friends and colleagues in China, and were delivered to the ICGEB Trieste on 23 April 2020. ICGEB has liaised with the Italian Regional Health Authority to ensure distribution of the masks to local health authorities."

The ICGEB in Trieste, Italy has received a consignment of protective masks from its Chinese partners in Beijing and Taizhou.

Editor:余昊原

Top News

  • At 6:57 a.m. on September 3, Air China CA746 carrying passengers from Phnom Penh, Cambodia, landed at Beijing Capital International Airport. It was the first international flight to Beijing Capital International Airport since the Civil Aviation Administration of China announced the gradual resumption of direct international flights to Beijing without passing through one of the designated first points of entry into China.

Haploid induction greatly speeds up maize breeding process

The new haploid breeding technology has significantly sped up the process of maize breeding in China, said Dai Jingrui, an academician of the Chinese Academy of Engineering (CAE) and a professor at China Agricultural University (CAU).

A Future to Expect: International S&T Community Expresses High Hope in Cooperation with Peers in China

According to the latest news from Science and Technology Daily (April 14th), two COVID-19 inactivated vaccines were just approved for a phase I & II combined clinical trial by the National Medical Products Administration (NMPA) of China, making them the first batch in this category. The two vaccines were developed respectively by Wuhan Institute of Biological Products Co., Ltd of Sinopharm and Sinovac Research & Development Co., Ltd together with research institutes.

Copyright ? Science and Technology Daily, All Rights Reserved

mailto: yuhy@stdaily.com